Silymarin
Silymarin is extracted from Milk Thistle. Stanford Chemicals has been providing quality Silymarin and many other natural plant extract for over 15 years.
Product Name |
Silymarin |
CAS No. |
65666-07-1 |
Molecular Formula |
C25H22O10 |
Molecular Weight |
482.44 |
Purity |
98% HPLC |
Package |
25 kg/drum |
Silymarin Safety Tips
Handling of Silymarin should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes.
Related Products
-
Product Name: Silybin
CAS No.: 22888-70-6
Molecular Formula: C25H22O10
Molecular Weight: 482.44
Purity: 20%-98% HPLC
Package: 25 kg/drum
-
Product Name: Ursolic Acid
CAS No.: 77-52-1
Molecular Formula: C30H48O3
Molecular Weight: 456.7
Purity: 20-98% HPLC
Package: 25 kg/drum
-
Loquat Leaf Extract, Specification: 25% Ursolic acid HPLC; 20%-98% Ursolic acid HPLC . Botanical Source: Loquat Leaf; Eriobotrya Japonica (Thunb.) Lindl..
-
Milk Thistle Extract, Specification: 80% Silymarin UV/HPLC 30%-40% Silybin HPLC; 20%-45% UV water soluble. Botanical Source: Milk Thistle.
References
- 1. Synchronized and controlled release of multiple components in silymarin achieved by the osmotic release strategy.
Xie Y, Lu Y, Qi J, Li X, Zhang X, Han J, Jin S, Yuan H, Wu W.Int J Pharm. 2012 Dec 16. doi:pii: S0378-5173(12)01061-7. 10.1016/j.ijpharm.2012.12.007. [Epub ahead of print]
- 2. Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B.
Wei F, Liu SK, Liu XY, Li ZJ, Li B, Zhou YL, Zhang HY, Li YW.Eur J Clin Microbiol Infect Dis. 2012 Dec 18. [Epub ahead of print]
- 3. [Silibinin and its hepatoprotective action from the perspective of a toxicologist].
Kostek H, Szponar J, Tchórz M, Majewska M, Lewandowska-Stanek H.Przegl Lek. 2012;69(8):541-3. Polish.
- 4. Herbal Supplement Ameliorates Cardiac Hypertrophy in Rats with CCl(4)-Induced Liver Cirrhosis.
Li PC, Chiu YW, Lin YM, Day CH, Hwang GY, Pai P, Tsai FJ, Tsai CH, Kuo YC, Chang HC, Liu JY, Huang CY.Evid Based Complement Alternat Med. 2012;2012:139045. doi: 10.1155/2012/139045. Epub 2012 Nov 6.
- 5. Protective effects of natsumikan (Citrus natsudaidai) extract on acetaminophen-induced lethal hepatotoxicity in mice.
Yamaura K, Nakayama N, Shimada M, Ueno K.Pharmacognosy Res. 2012 Oct;4(4):234-6. doi: 10.4103/0974-8490.102274.
- 6. Hepatoprotective and antiviral functions of silymarin components in HCV infection.
Polyak SJ, Ferenci P, Pawlotsky JM.Hepatology. 2012 Dec 5. doi: 10.1002/hep.26179. [Epub ahead of print] No abstract available.
- 7. Effects of single or repeated silymarin administration on pharmacokinetics of risperidone and its major metabolite, 9-hydroxyrisperidone in rats.
Lee KS, Chae SW, Park JH, Park JH, Choi JM, Rhie SJ, Lee HJ.Xenobiotica. 2012 Dec 20. [Epub ahead of print]
- 8. Protective effect of silymarin during coronary artery bypass grafting surgery.
Altaei T.Exp Clin Cardiol. 2012 Winter;17(1):34-8.
- 9. Evaluation of the Hepatoprotective Effects of Lantadene A, a Pentacyclic Triterpenoid of Lantana Plants against Acetaminophen-induced Liver Damage.
Grace-Lynn C, Chen Y, Latha LY, Kanwar JR, Jothy SL, Vijayarathna S, Sasidharan S.Molecules. 2012 Nov 23;17(12):13937-47. doi: 10.3390/molecules171213937.
- 10. Pharmacological evaluation of mangiferin herbosomes for antioxidant and hepatoprotection potential against ethanol induced hepatic damage.
Jain PK, Kharya M, Gajbhiye A.Drug Dev Ind Pharm. 2012 Nov 20. [Epub ahead of print]
- 11. Effect of Topical Application of Silymarin (Silybum marianum) on Excision Wound Healing in Albino Rats.
Sharifi R, Rastegar H, Kamalinejad M, Dehpour AR, Tavangar SM, Paknejad M, Mehrabani Natanzi M, Ghannadian N, Akbari M, Pasalar P.Acta Med Iran. 2012 Sep;50(9):583-8.
- 12. Biochemical and molecular mechanisms of N-acetyl cysteine and silymarin-mediated protection against maneb- and paraquat-induced hepatotoxicity in rats.
Ahmad I, Shukla S, Kumar A, Singh BK, Kumar V, Chauhan AK, Singh D, Pandey HP, Singh C.Chem Biol Interact. 2012 Nov 16;201(1-3):9-18. doi: 10.1016/j.cbi.2012.10.027. [Epub ahead of print]
- 13. Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L.
Saeed N, Khan MR, Shabbir M.BMC Complement Altern Med. 2012 Nov 16;12:221. doi: 10.1186/1472-6882-12-221.
- 14. Effect of Smilax zeylanica roots and rhizomes in paracetamol induced hepatotoxicity.
Murali A, Ashok P, Madhavan V.J Complement Integr Med. 2012 Nov 9;9(1). doi:pii: /j/jcim.2012.9.issue-1/1553-3840.1639/1553-3840.1639.xml. 10.1515/1553-3840.1639.
- 15. Treatment with silymarin for hepatitis C virus.
Ferenci P.JAMA. 2012 Nov 14;308(18):1856-7; author reply 1857. doi: 10.1001/jama.2012.13741. No abstract available.
- 16. Protective effect of Mollugo nudicaulis Lam. on acute liver injury induced by perchloroethylene in experimental rats.
Rajamanikandan S, Sindhu T, Durgapriya D, Sophia D, Ragavendran P, Gopalakrishnan VK.Asian Pac J Trop Med. 2012 Nov;5(11):862-7. doi: 10.1016/S1995-7645(12)60161-8.
- 17. Hepatoprotective effects of Gentiana asclepiadea L. extracts against carbon tetrachloride induced liver injury in rats.
Mihailovi? V, Mihailovi? M, Uskokovi? A, Arambaši? J, Miši? D, Stankovi? V, Katani? J, Mladenovi? M, Soluji? S, Mati? S.Food Chem Toxicol. 2012 Nov 9;52C:83-90. doi: 10.1016/j.fct.2012.10.034. [Epub ahead of print]
- 18. Potential antioxidant properties and hepatoprotective effects of an aqueous extract formula derived from three Chinese medicinal herbs against CCl(4)-induced liver injury in rats.
Yang CC, Fang JY, Hong TL, Wang TC, Zhou YE, Lin TC.Int Immunopharmacol. 2012 Nov 7. doi:pii: S1567-5769(12)00309-8. 10.1016/j.intimp.2012.10.017. [Epub ahead of print]
- 19. Silymarin for diabetic nephropathy: the challenges of botanical product research.
Meyers CM, Briggs JP.Am J Kidney Dis. 2012 Dec;60(6):887-9. doi: 10.1053/j.ajkd.2012.09.002. No abstract available.
- 20. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
Xu HM, Chen Y, Xu J, Zhou Q.World J Gastroenterol. 2012 Nov 7;18(41):5972-8. doi: 10.3748/wjg.v18.i41.5972.